Trials / Recruiting
RecruitingNCT04062500
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,500 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.
Detailed description
Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients. 1. To elucidate the clinical characteristics and prognostic risks of patients with heart failure. 2. To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients. 3. To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects. 4. To investigate the effect of self-management on outcomes in patients with heart failure. 5. To elucidate critical factors associated with the development and outcomes of heart failure. 6. To investigate hospitalization expenses for heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mortality and Rehospitalization rate | Mortality and Re-hospitalization of acute decompensated heart failure |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2020-12-31
- Completion
- 2027-12-31
- First posted
- 2019-08-20
- Last updated
- 2020-08-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04062500. Inclusion in this directory is not an endorsement.